欧美日韩精品无码专区,成年无码av片,成品漫画免登录去广告版,亚洲精品一区国产

上海非利加實(shí)業(yè)有限公司Logo

熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁(yè) > 所有品牌 > Tau Therapeutics
Tau Therapeutics
Tau Therapeutics Tau Therapeutics

美國(guó)Tau Therapeutics
研發(fā)的T型鈣通道阻滯劑米貝拉地爾(mibefradil)用于實(shí)體腫瘤的治療。


Tau Therapeutics is developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel. The company’s approach, called Interlaced Therapy?, capitalizes on the central role of calcium influx through T-type calcium channels during cancer cell growth. T-type calcium channel blockade with Tau’s drugs arrests tumor cells at their most vulnerable metabolic point in the cell cycle, uniquely amplifying the effects of conventional therapies and overcoming drug resistance.

Tau’s first product, mibefradil, has been used extensively in humans and its safety profile is well known. Mibefradil is now entering clinical trials for brain cancer with support from the NCI.

Tau Therapeutics is a private company based in Charlottesville, VA.
 

關(guān)于我們客戶(hù)服務(wù)產(chǎn)品分類(lèi)法律聲明